Report of an NIAID workshop on dengue animal models

Vaccine

Volumn 28, Issue 26, 2010, Pages 4229-4234

  Cassetti, M Cristina ^a   Durbin, Anna ^b   Harris, Eva ^c   Rico Hesse, Rebeca ^d   Roehrig, John ^e   Rothman, Alan ^f   Whitehead, Stephen ^a   Natarajan, Ramya ^a   Laughlin, Catherine ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Animal; Dengue; Models

Indexed keywords

ANTIVIRUS AGENT; DENGUE VACCINE; INTERFERON RECEPTOR;

AEDES AEGYPTI; AEDES ALBOPICTUS; ANTIBODY TITER; CONFERENCE PAPER; DENGUE; DENGUE VIRUS; DISEASE MODEL; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; INCIDENCE; INFECTION RISK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINE PRODUCTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; BIOMEDICAL RESEARCH; DENGUE; DENGUE VACCINES; HUMANS; MACACA MULATTA; MICE; MODELS, ANIMAL; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (U.S.); PAN TROGLODYTES; SWINE; SWINE, MINIATURE; UNITED STATES;

EID: 77952741733     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.045     Document Type: Conference Paper

References (44)

1. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10 2 (2002) 100-103
2. WHO. Dengue haemorrhagic fever: diagnosis, treatment prevention and control (1997), WHO, Geneva
3. Lindenbach B.D., Thiel H.J., and Rice C.M. Flaviviridae: the viruses and their replicatio. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. fifth ed. vol. 1 (2007), Lippincott Williams and Wilkins, Baltimore 1101-1152
4. Gubler J.D., Kuno G., and Markoff L. Flaviviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. fifth ed. vol. 1 (2007), Lippincott Williams and Wilkins, Baltimore 1153-1252
5. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., and Suntayakorn S. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181 (2000) 2-9
6. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60 (2003) 421-467
7. Mathew A., and Rothman A.L. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225 October (2008) 300-313
8. Chen H.C., Hofman F.M., Kung J.T., Lin Y.D., and Wu-Hsieh B.A. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81 June (11) (2007) 5518-5526
9. Paes M.V., Pinhão A.T., Barreto D.F., Costa S.M., Oliveira M.P., Nogueira A.C., et al. Liver injury and viremia in mice infected with dengue-2 virus. Virology 338 August 1 (2) (2005) 236-246
10. + T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. Viral Immunol 22 3 (2009) 215-219
11. Bente D.A., Melkus M.W., Garcia J.V., and Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol 79 21 (2005) 13797-13799
12. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 106 September 1 (5) (2005) 1565-1573
13. Mota J., and Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 83 (2009) 8638-8645
14. Kuruvilla J.G., Troyer R.M., Devi S., and Akkina R. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology 369 1 (2007) 143-152
15. van den Broek M.F., Müller U., Huang S., Aguet M., and Zinkernagel R.M. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69 8 (1995) 4792-4796
16. van den Broek M.F., Müller U., Huang S., Zinkernagel R.M., and Aguet M. Immune defense in mice lacking type I and/or type II interferon receptors. Immunol Rev 148 (1995) 5-18
17. Johnson A.J., and Roehrig J.T. New mouse model for dengue virus vaccine testing. J Virol 73 1 (1999) 783-786
18. Shresta S., Sharar K.L., Prigozhin D.M., Beatty P.R., and Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 80 20 (2006) 10208-10217
19. Williams K.L., Zompi S., Beatty P.R., and Harris E. A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci 1171 Suppl. 1 (2009) E12-E23
20. Balsitis S.J., Williams K.L., Lachica R., Flores D., Kyle J.L., Mehlhop E., et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6 February 12 (2) (2010)
21. Zellweger R.M., Prestwood T.R., and Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7 February 18 (2) (2010) 128-139
22. + T cells. J Immunol 182 April 15 (8) (2009) 4865-4873
23. Burke D.S., and Monath T.P. Flaviviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. fourth ed. vol. 1 (2001), Lippincott Williams and Wilkins, Baltimore 1043-1125
24. Simmons J.S., St John J.H., and Reynolds F.H.K. Experimental studies of dengue. Philippine J Sci 44 (1931) 1-252
25. Halstead S.B., Casals J., Shotwell H., and Palumbo N. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg 22 (1973) 365-374
26. Halstead S.B., Shotwell H., and Casals J. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis 128 (1973) 7-14
27. Halstead S.B., Shotwell H., and Casals J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 128 (1973) 15-22
28. Scherer W.F., Russell P.K., Rosen L., Casals J., and Dickerman R.W. Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg 27 (1978) 590-599
29. Durbin A.P., Karron R.A., Sun W., Vaughn D.W., Reynolds M.J., Perreault J.R., et al. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 65 (2001) 405-413
30. McArthur J.H., Durbin A.P., Marron J.A., Wanionek K.A., Thumar B., Pierro D.J., et al. Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am J Trop Med Hyg 79 (2008) 678-684
31. Men R., Yamashiro T., Goncalvez A.P., Wernly C., Schofield D.J., Emerson S.U., et al. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus. J Virol 78 9 (2004) 4665-4674
32. Ehrlich P.H., Moustafa Z.A., Harfeldt K.E., Isaacson C., and Ostberg L. Potential of primate monoclonal antibodies to substitute for human antibodies: nucleotide sequence of chimpanzee Fab fragments. Hum Antibodies Hybrid 1 1 (1990) 23-26
33. Ueda S., Matsuda F., and Honjo T. Multiple recombinational events in primate immunoglobulin epsilon and alpha genes suggest closer relationship of humans to chimpanzees than to gorillas. J Mol Evol 27 1 (1988) 77-83
34. Lai C.J., Goncalvez A.P., Men R., Wernly C., Donau O., Engle R.E., et al. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. J Virol 81 23 (2007) 12766-12774
35. Goncalvez A.P., Engle R.E., St Claire M., Purcell R.H., and Lai C.J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A 104 22 (2007) 9422-9427
36. McGee C.E., Lewis M.G., Claire MSClaire M.S., Lang J., Guy B., Tsetsarkin K., et al. Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates. J Infect Dis 198 September 1 (5) (2008) 794-795
37. Blaney Jr. J.E., Johnson D.H., Manipon G.G., Firestone C.Y., Hanson C.T., Murphy B.R., et al. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 300 August 15 (1) (2002) 125-139
38. Hanley K.A., Manlucu L.R., Manipon G.G., Hanson C.T., Whitehead S.S., Murphy B.R., et al. Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity. Vaccine 22 (2004) 3440-3448
39. Blaney Jr. J.E., Durbin A.P., Murphy B.R., and Whitehead S.S. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol 19 Spring (1) (2006) 10-32
40. Sun W., Nisalak A., Gettayacamin M., Eckels K.H., Putnak J.R., Vaughn D.W., et al. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 193 June 15 (12) (2006) 1658-1665
41. Robert Putnak J., Coller B.A., Voss G., Vaughn D.W., Clements D., Peters I., et al. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine 23 August 15 (35) (2005) 4442-4452
42. Blaney Jr. J.E., Matro J.M., Murphy B.R., and Whitehead S.S. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol 79 May (9) (2005) 5516-5528
43. Schul W., Liu W., Xu H.Y., Flamand M., and Vasudevan S.G. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis 195 5 (2007) 665-674
44. Yin Z., Chen Y.L., Schul W., Wang Q.Y., Gu F., Duraiswamy J., et al. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A 106 December 1 (48) (2009) 20435-20439